Accounting for Equity Incentives in MBOs: Applying Hong Kong Financial Reporting Standard 2

The market for management buyouts (MBOs) in Hong Kong is undergoing a structural recalibration, driven not by cheap debt but by the tightening intersection of accounting standards and sponsor scrutiny. Since the HKICPA’s 2023 issuance of an exposure draft clarifying the application of HKFRS 2 Share-based Payment to leveraged buyout structures, dealmakers have been forced to re-evaluate how equity incentives granted to incumbent management are priced and disclosed. The specific flashpoint arises when a buyout vehicle—typically a BVI or Cayman-incorporated special-purpose vehicle (SPV)—issues equity instruments to the management team at a price that is below the fair value of the SPV’s underlying shares. Under HKFRS 2, paragraph 2, this transaction triggers a share-based payment charge that must be recognised in the SPV’s profit or loss, regardless of whether the SPV itself is the issuer of the equity. For a Hong Kong-listed target being taken private via an MBO, this accounting treatment can materially inflate the transaction’s reported cost base, reducing post-acquisition earnings per share and complicating the sponsor’s internal rate of return (IRR) projections. The SFC’s 2024 thematic review of MBO-related filings further underscored that insufficient disclosure of these incentive structures under the Code on Takeovers and Mergers (Takeovers Code) Rule 8.2 was a recurrent deficiency. This article dissects the precise accounting mechanics under HKFRS 2, the regulatory disclosure obligations under the Takeovers Code and the Hong Kong Listing Rules, and the structuring implications for PE sponsors executing MBOs in the 2025-2026 cycle.

The HKFRS 2 Trigger: When an MBO Equity Incentive Becomes a Share-Based Payment

The core accounting problem in an MBO is that the management team is typically granted equity in the acquisition vehicle—a newly formed SPV—at a price per share that is lower than the fair value of that share. This discount represents compensation for the management team’s continued service and their alignment with the sponsor’s exit strategy. HKFRS 2 applies to any transaction where an entity receives goods or services in exchange for its own equity instruments. In the context of an MBO, the “service” is the management team’s post-acquisition employment, and the “equity instruments” are the shares or options in the SPV.

Classification of the Grant: Equity-Settled vs. Cash-Settled

The first determination under HKFRS 2, paragraphs 30-43, is whether the arrangement is equity-settled or cash-settled. In a standard Hong Kong MBO structure, where the sponsor (e.g., Baring Private Equity Asia, KKR, or a local family office) and management subscribe for shares in a Cayman-incorporated SPV, the grant is classified as equity-settled. The SPV issues shares to management at a subscription price that is below the fair value per share determined by the sponsor’s independent valuer. The difference between the subscription price and the fair value on the grant date is the share-based payment expense.

This expense is recognised over the vesting period—typically three to five years, matching the sponsor’s planned holding period. The measurement date is the grant date, and the fair value of the equity instruments is estimated using an appropriate valuation model, often a Black-Scholes or Monte Carlo simulation, as required by HKFRS 2, paragraph 16. The key input is the fair value of the SPV’s underlying shares, which is itself derived from the enterprise value of the target company, adjusted for the SPV’s debt structure.

Measurement at Grant Date: The Valuation Challenge

The valuation of the SPV’s shares at grant date is the most contentious area. Unlike a listed company with a readily observable market price, the SPV’s shares have no active market. The sponsor’s valuation team, or an external valuer, must estimate the fair value based on the target’s projected cash flows, the SPV’s capital structure, and the expected exit timeline.

A common error in MBO accounting is using the sponsor’s own subscription price as a proxy for fair value. This is incorrect under HKFRS 2, paragraph 14. The sponsor’s subscription price may include a control premium or reflect strategic synergies, whereas the management’s equity grant is for service compensation. The fair value of the management’s shares must be measured independently. For example, if the sponsor subscribes at HKD 100 per share and management subscribes at HKD 60 per share, the HKD 40 discount is the share-based payment expense per share granted. If management receives 1,000,000 shares, the total pre-vesting expense is HKD 40,000,000, recognised over the vesting period.

Modifications and Cancellations: Post-Acquisition Adjustments

MBOs frequently involve modifications to the equity incentive plan after the acquisition is completed. A common scenario is a “good leaver” provision where a departing manager forfeits unvested shares, or a “bad leaver” provision where shares are repurchased at cost. Under HKFRS 2, paragraphs 27-29, a cancellation (e.g., when a manager leaves) results in the immediate recognition of any remaining unvested expense. A modification that increases the fair value of the grant (e.g., reducing the exercise price of an option) requires incremental expense recognition at the modification date.

These adjustments can create significant volatility in the SPV’s profit or loss during the holding period. A sponsor projecting a 20% IRR must model the impact of a potential 50% management turnover, which could accelerate HKD 20 million in share-based payment charges into a single year, reducing net income and potentially triggering debt covenant breaches under the SPV’s financing agreements.

Regulatory Disclosure Requirements Under the Takeovers Code and Listing Rules

The accounting treatment under HKFRS 2 does not exist in a vacuum. The SFC and HKEX require detailed disclosure of MBO equity incentive plans, both in the takeover document and in the target company’s continuing obligations if it remains listed (e.g., in a partial MBO or a privatisation via a scheme of arrangement).

Takeovers Code Rule 8.2: The Offer Document

Under the Takeovers Code, Rule 8.2, the offer document for a general offer must include “full particulars” of any arrangement under which the offeror has provided or will provide equity incentives to the offeree company’s management. This includes the number of shares, the subscription price, the vesting schedule, and the fair value of the instruments. The SFC’s 2024 thematic review found that 12 of 22 MBO offer documents reviewed failed to disclose the fair value measurement methodology, relying instead on a statement that the subscription price was “determined by reference to the offer price.”

This is insufficient. The SFC’s published guidance (December 2024) explicitly states that the fair value of the equity instruments must be stated, along with the valuation model used and the key assumptions (e.g., discount rate, volatility, expected term). Failure to comply can result in the SFC requiring a supplementary offer document, delaying the timetable by 14 to 21 days under the Takeovers Code.

Listing Rules Chapter 17: Share Option Schemes and Equity Incentives

If the target company is listed on the Main Board of HKEX, the MBO equity incentive plan may also be subject to the Listing Rules, Chapter 17, which governs share option schemes. While a privatisation MBO typically results in the cancellation of the target’s listing, a partial MBO or a scheme that leaves a minority free float requires the plan to comply with Chapter 17.

Chapter 17, Rule 17.03(3) requires that the exercise price of options must not be less than the higher of the closing price on the date of grant and the average closing price for the five trading days immediately preceding the grant date. In an MBO context, where the grant date may occur before the offer is completed, the “closing price” is the last traded price of the target company’s shares. This creates a floor price that may be above the management’s subscription price, forcing the sponsor to structure the incentive as a restricted share grant rather than an option to avoid breaching the Listing Rules.

The SFC’s 2024 Thematic Review: Recurring Deficiencies

The SFC’s thematic review, published in December 2024, identified three recurring deficiencies in MBO equity incentive disclosures:

1. Lack of fair value disclosure: 12 of 22 offer documents did not state the fair value of the equity instruments.
2. Inadequate vesting schedule description: 8 of 22 offer documents omitted the specific performance conditions (e.g., EBITDA targets, exit IRR thresholds) that trigger vesting.
3. Missing accounting policy note: 15 of 22 offer documents did not include a statement that the equity incentive plan would be accounted for under HKFRS 2.

These findings are directly relevant to sponsors and their legal advisors. The SFC has indicated that future MBO filings will be subject to enhanced scrutiny, and that non-compliance may result in enforcement action under the Securities and Futures Ordinance (Cap. 571), Section 277 (misleading statements).

Structuring Implications for PE Sponsors: Mitigating the Accounting and Regulatory Impact

Given the accounting charge under HKFRS 2 and the regulatory disclosure requirements, PE sponsors must structure MBO equity incentives with precision. Three structuring approaches are commonly used in Hong Kong MBOs.

Approach 1: The “Market Price” Subscription

The simplest approach is to require management to subscribe for SPV shares at the same price per share as the sponsor. This eliminates the share-based payment charge because there is no discount. However, this approach is rarely practical because management typically lacks the capital to subscribe at the full sponsor price. A variant is to provide management with a loan from the SPV or the sponsor to fund the subscription, but this creates a related-party transaction that must be disclosed under the Listing Rules, Chapter 14A, and may trigger interest income recognition for the lender.

Approach 2: The “Phantom Equity” or Cash-Settled Plan

Instead of granting equity in the SPV, the sponsor can implement a cash-settled share appreciation right (SAR) plan. Under HKFRS 2, paragraphs 30-33, a cash-settled plan is remeasured at each reporting date until settlement, with changes in fair value recognised in profit or loss. This avoids the upfront measurement complexity of the equity-settled approach but introduces earnings volatility because the expense fluctuates with the SPV’s estimated fair value.

For a sponsor targeting a 2028 exit, a cash-settled plan with a five-year vesting period will generate an annual expense equal to the change in the SPV’s fair value multiplied by the number of vested but unexercised SARs. If the SPV’s value doubles, the expense also doubles, potentially reducing the sponsor’s net equity value at exit. This approach is more common in MBOs where the sponsor is a financial institution that prefers to keep the management team off the SPV’s cap table for regulatory capital reasons.

Approach 3: The “Performance-Based Vesting” Structure

The most sophisticated approach, and the one favoured by Hong Kong-based sponsors such as Affinity Equity Partners and RRJ Capital, is to link vesting to specific performance conditions that are objectively measurable. Under HKFRS 2, paragraph 21, the expense is recognised only when it is probable that the performance condition will be met. This can defer the recognition of a significant portion of the expense until the target company’s EBITDA or revenue reaches a predefined threshold.

For example, an MBO of a Hong Kong-listed industrial company might grant management 2,000,000 SPV shares at a 40% discount to sponsor price, with vesting conditional on the target achieving HKD 500 million in cumulative EBITDA over three years. If the probability of achieving this target is assessed as 60% at grant date, only 60% of the total expense is recognised over the vesting period. If the target is not met, the unvested shares are forfeited and the expense is reversed. This aligns the accounting charge with actual value creation, reducing the risk of a large upfront expense that depresses reported earnings.

The Interaction with Debt Covenants and Sponsor IRR

The share-based payment expense under HKFRS 2 directly impacts the SPV’s consolidated profit or loss. In a typical LBO structure, the SPV is the parent company that consolidates the target. The share-based payment charge flows through to the SPV’s income statement, reducing net income. This, in turn, affects the SPV’s ability to service its debt, because most LBO loan agreements include a fixed charge coverage ratio (FCCR) covenant.

A standard FCCR covenant in a Hong Kong LBO might require the SPV to maintain an FCCR of at least 1.20x. If the share-based payment charge reduces EBITDA (or adjusted EBITDA) by HKD 40 million, the FCCR calculation is impaired. The sponsor must either negotiate an add-back for share-based payment in the loan agreement (common, but not universal) or accept a lower leverage ratio.

The impact on sponsor IRR is equally direct. The share-based payment charge reduces the SPV’s distributable reserves, which limits the amount of dividends that can be paid to the sponsor during the holding period. If the sponsor’s base case IRR of 22% assumes HKD 100 million in annual dividends, a HKD 15 million annual share-based payment charge reduces the dividend stream to HKD 85 million, dropping the IRR to approximately 20.5% (assuming a 5-year hold and a 3x exit multiple). This 150 bps reduction is material for a fund with a 20% target return.

Practical Takeaways for MBO Execution in 2025-2026

MBO equity incentives are not a tax or legal afterthought; they are a core accounting and regulatory consideration that affects deal economics from day one. The following takeaways are derived from the analysis above and the current regulatory environment in Hong Kong.

1. Engage an independent valuer at the term sheet stage. The fair value of the SPV’s shares must be determined before the grant date to avoid a retrospective accounting adjustment under HKFRS 2, paragraph 14. The valuer should use a methodology consistent with the sponsor’s enterprise value model.

2. Disclose the full fair value in the offer document. The SFC’s 2024 thematic review makes clear that a simple reference to the offer price is insufficient. The fair value, valuation model, and key assumptions must be stated under Takeovers Code Rule 8.2.

3. Model the accounting impact on debt covenants. The share-based payment charge reduces net income and can impair FCCR calculations. Negotiate an explicit add-back for share-based payment in the loan agreement to avoid a technical default.

4. Link vesting to objective performance conditions. Performance-based vesting defers expense recognition under HKFRS 2, paragraph 21, reducing the upfront drag on reported earnings and aligning the accounting charge with actual value creation.

5. Consider a cash-settled plan for regulatory capital efficiency. If the sponsor is subject to capital adequacy requirements (e.g., a bank-sponsored PE fund), a cash-settled SAR plan avoids the equity dilution issue and may be treated more favourably under the HKMA’s Supervisory Policy Manual on capital treatment of investments.